199 related articles for article (PubMed ID: 33639614)
1. Follistatin-like 1 deficiency impairs T cell development to promote lung metastasis of triple negative breast cancer.
Ma J; Yang Y; Wang L; Jia X; Lu T; Zeng Y; Liu L; Gao Y
Aging (Albany NY); 2021 Feb; 13(5):7211-7227. PubMed ID: 33639614
[TBL] [Abstract][Full Text] [Related]
2. FSTL1 enhances chemoresistance and maintains stemness in breast cancer cells via integrin β3/Wnt signaling under miR-137 regulation.
Cheng S; Huang Y; Lou C; He Y; Zhang Y; Zhang Q
Cancer Biol Ther; 2019; 20(3):328-337. PubMed ID: 30336071
[TBL] [Abstract][Full Text] [Related]
3. Group 2 innate lymphoid cells promote TNBC lung metastasis via the IL-13-MDSC axis in a murine tumor model.
Zhao N; Zhu W; Wang J; Liu W; Kang L; Yu R; Liu B
Int Immunopharmacol; 2021 Oct; 99():107924. PubMed ID: 34217145
[TBL] [Abstract][Full Text] [Related]
4. FSTL1 Suppresses Triple-Negative Breast Cancer Lung Metastasis by Inhibiting M2-like Tumor-Associated Macrophage Recruitment toward the Lungs.
Yang Y; Lu T; Jia X; Gao Y
Diagnostics (Basel); 2023 May; 13(10):. PubMed ID: 37238210
[TBL] [Abstract][Full Text] [Related]
5. Follistatin-like 1 mitigates intermittent hypoxia-induced melanoma lung metastasis in mice.
Qi C; Cao J; Liu X; Chen Q; Liang M; Chen Z; Feng J; Chen B; Ning W; Li L
Sleep Breath; 2023 Jun; 27(3):1165-1173. PubMed ID: 36115873
[TBL] [Abstract][Full Text] [Related]
6. Follistatin-like Protein 1 Inhibits Lung Cancer Metastasis by Preventing Proteolytic Activation of Osteopontin.
Chiou J; Chang YC; Tsai HF; Lin YF; Huang MS; Yang CJ; Hsiao M
Cancer Res; 2019 Dec; 79(24):6113-6125. PubMed ID: 31653686
[TBL] [Abstract][Full Text] [Related]
7. Myeloid-derived suppressor cell depletion therapy targets IL-17A-expressing mammary carcinomas.
Dawod B; Liu J; Gebremeskel S; Yan C; Sappong A; Johnston B; Hoskin DW; Marshall JS; Wang J
Sci Rep; 2020 Aug; 10(1):13343. PubMed ID: 32770025
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of Follistatin-Like Protein 1 Accelerates the Growth of Breast Cancer Cells at Lung Metastatic Sites.
Zhang Y; Xu X; Yang Y; Ma J; Wang L; Meng X; Chen B; Qin L; Lu T; Gao Y
J Breast Cancer; 2018 Sep; 21(3):267-276. PubMed ID: 30275855
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic inactivation of follistatin-like 1 mediates tumor immune evasion in nasopharyngeal carcinoma.
Zhou X; Xiao X; Huang T; Du C; Wang S; Mo Y; Ma N; Murata M; Li B; Wen W; Huang G; Zeng X; Zhang Z
Oncotarget; 2016 Mar; 7(13):16433-44. PubMed ID: 26918942
[TBL] [Abstract][Full Text] [Related]
10. FSTL1 Promotes Metastasis and Chemoresistance in Esophageal Squamous Cell Carcinoma through NFκB-BMP Signaling Cross-talk.
Lau MC; Ng KY; Wong TL; Tong M; Lee TK; Ming XY; Law S; Lee NP; Cheung AL; Qin YR; Chan KW; Ning W; Guan XY; Ma S
Cancer Res; 2017 Nov; 77(21):5886-5899. PubMed ID: 28883005
[TBL] [Abstract][Full Text] [Related]
11. Cell type specific expression of Follistatin-like 1 (Fstl1) in mouse embryonic lung development.
Liu X; Liu Y; Yang Z; Ning W
J Mol Histol; 2018 Aug; 49(4):399-409. PubMed ID: 29916090
[TBL] [Abstract][Full Text] [Related]
12. FSTL1 interacts with VIM and promotes colorectal cancer metastasis via activating the focal adhesion signalling pathway.
Gu C; Wang X; Long T; Wang X; Zhong Y; Ma Y; Hu Z; Li Z
Cell Death Dis; 2018 May; 9(6):654. PubMed ID: 29844309
[TBL] [Abstract][Full Text] [Related]
13. Targeting FSTL1 prevents tumor bone metastasis and consequent immune dysfunction.
Kudo-Saito C; Fuwa T; Murakami K; Kawakami Y
Cancer Res; 2013 Oct; 73(20):6185-93. PubMed ID: 23966294
[TBL] [Abstract][Full Text] [Related]
14. Follistatin-like 1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling antagonist in controlling mouse lung development.
Geng Y; Dong Y; Yu M; Zhang L; Yan X; Sun J; Qiao L; Geng H; Nakajima M; Furuichi T; Ikegawa S; Gao X; Chen YG; Jiang D; Ning W
Proc Natl Acad Sci U S A; 2011 Apr; 108(17):7058-63. PubMed ID: 21482757
[TBL] [Abstract][Full Text] [Related]
15. CC chemokine receptor 7 promotes triple-negative breast cancer growth and metastasis.
Wu J; Li L; Liu J; Wang Y; Wang Z; Wang Y; Liu W; Zhou Z; Chen C; Liu R; Yang R
Acta Biochim Biophys Sin (Shanghai); 2018 Sep; 50(9):835-842. PubMed ID: 30032244
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer.
Steenbrugge J; Breyne K; Demeyere K; De Wever O; Sanders NN; Van Den Broeck W; Colpaert C; Vermeulen P; Van Laere S; Meyer E
J Exp Clin Cancer Res; 2018 Aug; 37(1):191. PubMed ID: 30111338
[TBL] [Abstract][Full Text] [Related]
17. Fatty acid binding protein 5 promotes metastatic potential of triple negative breast cancer cells through enhancing epidermal growth factor receptor stability.
Powell CA; Nasser MW; Zhao H; Wochna JC; Zhang X; Shapiro C; Shilo K; Ganju RK
Oncotarget; 2015 Mar; 6(8):6373-85. PubMed ID: 25779666
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II promotes primary tumor growth and metastasis formation of murine TNBC 4T1 cells through the fibroblasts around cancer cells.
Takiguchi T; Takahashi-Yanaga F; Ishikane S; Tetsuo F; Hosoda H; Arioka M; Kitazono T; Sasaguri T
Eur J Pharmacol; 2021 Oct; 909():174415. PubMed ID: 34375673
[TBL] [Abstract][Full Text] [Related]
19. Mitotic cell death caused by follistatin-like 1 inhibition is associated with up-regulated Bim by inactivated Erk1/2 in human lung cancer cells.
Bae K; Park KE; Han J; Kim J; Kim K; Yoon KA
Oncotarget; 2016 Apr; 7(14):18076-84. PubMed ID: 26716515
[TBL] [Abstract][Full Text] [Related]
20. E3 Ubiquitin Ligase UBR5 Drives the Growth and Metastasis of Triple-Negative Breast Cancer.
Liao L; Song M; Li X; Tang L; Zhang T; Zhang L; Pan Y; Chouchane L; Ma X
Cancer Res; 2017 Apr; 77(8):2090-2101. PubMed ID: 28330927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
